COR Cencora, Inc. WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

Cencora (COR) Stock: Buy, Sell, or Hold?

$349.88
+1.17 (+0.34%) ▲
5d: -1.16% 30d: +5.99% 90d: +12.86%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (25%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$320.08 – $342.20
Position: EXTENDED
Forward P/E & Valuation
17.7x FAIR
vs 16.5x historical avg
Wall Street Target
$381.25
+9.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$326.34 / $363.95
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: COR shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When COR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$462.22
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$287.01
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: COR is currently trading at $349.88, which is considered extended relative to its 30-day fair value range of $320.08 to $342.20. The stock's valuation (Forward PE: 17.7) is in line with its historical norms (16.5). At these levels, the market is pricing in 2.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, COR is in a strong uptrend. Immediate support is located at $326.33, while resistance sits at $363.95.

Market Sentiment: COR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $320.08 - $342.20
Company Quality Score 37/100 (SELL)
Volume Confirmation HIGH
Confidence Score 24.8%

Trading Range & Key Levels

30-Day Trading Range $320.08 - $342.20
Current vs Trading Range EXTENDED
Support Level $326.34
Resistance Level $363.95
Current Trend Strong Uptrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding COR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($381.25)
  • NEUTRAL: Market pricing in 2.3% annual earnings growth - fairly valued
  • WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 17.70
Wall Street Target $381.25 (+9.0%)
Revenue Growth (YoY) 5.5%
Earnings Growth (YoY) 11.9%
Profit Margin 1.0%
Valuation Premium vs History +2.3% premium
PE vs Historical 17.7 vs 16.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.3% (market-implied from PE analysis)
1-Year Target $357.93 (+2%)
2-Year Target $366.16 (+5%)
3-Year Target $374.58 (+7%)
3-Yr Target (if PE normalizes) (PE: 18→17) PE COMPRESSION $349.13 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 10.5%) $529.95 (+52%)
Base: (SPY PE: 17.7, Growth: 10.5%) $472.38 (+35%)
Bear: (PE: 15.0, Growth: 10.5%) $401.52 (+15%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 19.27 | Current EPS (TTM): $18.10
Bull Case $418.85 (+20%)
Analyst growth 9.2%, PE expands to 21.2
Base Case $380.77 (+9%)
Market implied 9.2%, PE stable at 19.3
Bear Case $237.12 (-32%)
Severe decline -20.0%, PE contracts to 16.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share COR Analysis

Share this live COR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (COR)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 15, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish user on StockTwits mentioned $COR in the same tweet as $MCK, suggesting potential synergy or collaboration between the two companies.
Key Retail Themes: Company News Collaboration
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:00 AM ET
Data refreshes hourly during market hours. Next update: 5:00 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is COR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for COR.

Create Free Account

Already have an account? Log In

Top Rated Medical Distribution Stocks

Top-rated stocks in Medical Distribution by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
MCK
McKesson Corporation 		STRONG BUY
16 analysts 		$1129 37 SELL
CAH
Cardinal Health Inc 		STRONG BUY
17 analysts 		$292 30 SELL
HSIC
Henry Schein Inc 		BUY
16 analysts 		$97 49 HOLD
QIPT
Quipt Home Medical Corp 		STRONG BUY
5 analysts 		$4 52 HOLD
OMI
Owens & Minor Inc 		HOLD
6 analysts 		$6 46 HOLD
MCK McKesson Corporat…
37 SELL
CAH Cardinal Health I…
30 SELL
HSIC Henry Schein Inc
49 HOLD
QIPT Quipt Home Medica…
52 HOLD
OMI Owens & Minor Inc
46 HOLD

Advanced COR Option Strategies

Professional options setups generated by AI based on today's COR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive COR Research Pages
COR Technical Chart COR Price Prediction COR Intrinsic Value DCF COR Earnings Date COR Investment Advisor COR Fair Price Analyzer COR Options Chain COR Options Advisor COR Options Analysis COR Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (COR) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare COR with Peers
COR vs DLR
Which one to buy?
COR vs EQIX
Which one to buy?
COR vs EXR
Which one to buy?
COR vs CPT
Which one to buy?
COR vs ARE
Which one to buy?
COR vs CPT
WGRX vs COR
COR vs DLR
COR vs MCK
CAH vs COR
EDAP vs COR
COR vs ARE
COR vs AHG
ZYXI vs COR
COR vs EQIX
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals